Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy
about
Pigment epithelium-derived factor and its phosphomimetic mutant induce JNK-dependent apoptosis and p38-mediated migration arrestPEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseasesClinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients.Angiogenesis and chronic kidney disease.Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetesExpression of platelet-derived growth factor in the vascular walls of patients with lower extremity arterial occlusive disease.Virus integration and genome influence in approaches to stem cell based therapy for andro-urology.Pigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1.Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal InjuryExcretion of anti-angiogenic proteins in patients with chronic allograft dysfunction.Decreased K5 receptor expression in the retina, a potential pathogenic mechanism for diabetic retinopathyIdentification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seqRetinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathyRelationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy.TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by DiabetesIncreased serum pigment epithelium derived factor levels in Type 2 diabetes patients.Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.Effectiveness of rosiglitazone in reducing flexion contracture in a rabbit model of arthrofibrosis with surgical capsular release: A biomechanical, histological, and genetic analysisNanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakageThrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy.Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes.Intraglomerular crosstalk elaborately regulates podocyte injury and repair in diabetic patients: insights from a 3D multiscale modeling study.Advanced glycation end products, oxidative stress and diabetic nephropathy.The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies.PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reactionAnti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway.Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis.
P2860
Q24632971-70F3D308-A72B-480E-A3B6-4A8A77BE63FFQ27026916-A1DD20A4-5064-4CF2-BA77-D08367550A91Q33564001-CE5757B7-F9B1-4562-9F39-29D2E6D8907BQ34075013-FFF1CF29-4F93-4424-AE4C-26FD27C771B1Q34468107-CA48B555-172E-4267-A0CE-94483C8D4258Q35159534-EA7AD79E-457D-4386-B5AF-2EA4EC12A893Q35433757-8EDCCC40-AC80-4343-92B0-ABB06BCB915EQ35679338-5C4B9022-B2BE-49E1-9D6E-6D269CA5279EQ35710293-B33761AD-BCEA-4762-AF8B-5ACC2CEF4B99Q35745748-8EB88499-F377-41DD-8F58-4C317029163EQ35768511-70C305D3-3690-4B7D-B28B-BD9C25186751Q36195357-4E5734A8-2F8D-4F9B-A44F-39F09089D0F9Q36571714-63D1B4C6-C84F-40E6-B542-37A24367E8EFQ36688577-3F1CA5F0-B3AF-4AA2-98DB-76736BAF01BBQ36939054-B5076FDE-AFDE-4091-8EE5-513656AC05AEQ37001735-293C49C8-E7B9-47CC-B849-72D597F9586AQ37142636-6F24AD52-7013-45D5-8E53-853983D3BCF7Q37227633-DF3C7971-3423-4869-ADCF-81B727807D55Q37267083-BC415AF2-CA7D-443C-B00A-9A5CDB459C8CQ37283355-877A3DB2-DEC9-4FF7-8F1F-DF875499DA48Q37474427-13A4D3EE-37E9-451A-BF5F-4B5B447FB91EQ37687354-12EFC29C-274F-4145-B073-120B0E28990BQ37780646-68FAF487-38A7-429B-BEAB-E4C3070E56D5Q38103913-9E4B9638-F11D-407F-AD9A-83C9DEEAC77DQ38825960-FD017A80-FDCE-42B0-941C-0EA1E305BD8CQ41354166-F1CC1FD8-1F76-450A-BEA0-4D2331F96823Q46717201-90EBB90E-603C-4AAE-A85D-F2151B865717Q46923322-65EE3269-69B8-496E-A3EB-A124F0E9DF07Q51029813-14A8EAEE-4808-467F-97DD-73DC296BA51EQ51460655-A5BFFF71-56E4-4D11-968B-0DBA1ACD8CBD
P2860
Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy
description
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artikull shkencor
@sq
artículu científicu espublizáu en 2005
@ast
im Januar 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2005
@uk
مقالة علمية (نشرت عام 2005)
@ar
name
Decreased expression of pigmen ...... enesis of diabetic nephropathy
@ast
Decreased expression of pigmen ...... enesis of diabetic nephropathy
@en
Decreased expression of pigmen ...... enesis of diabetic nephropathy
@nl
type
label
Decreased expression of pigmen ...... enesis of diabetic nephropathy
@ast
Decreased expression of pigmen ...... enesis of diabetic nephropathy
@en
Decreased expression of pigmen ...... enesis of diabetic nephropathy
@nl
prefLabel
Decreased expression of pigmen ...... enesis of diabetic nephropathy
@ast
Decreased expression of pigmen ...... enesis of diabetic nephropathy
@en
Decreased expression of pigmen ...... enesis of diabetic nephropathy
@nl
P2093
P3181
P1433
P1476
Decreased expression of pigmen ...... enesis of diabetic nephropathy
@en
P2093
Jian-Xing Ma
Joshua J. Wang
Robert Mott
Sanai Sato
Sarah X. Zhang
P304
P3181
P356
10.2337/DIABETES.54.1.243
P407
P577
2005-01-01T00:00:00Z